Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Haploidentical NK Cells in Relapsed/Refractory Neuroblastoma
NCT00698009Phase 2Terminated
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jun 2008
- Primary completion
- Jun 2012
- Modality
- Lymphokine-Activated Killer Cells, CAR-NK Cells
- Countries
- 1
01
Overview
A Phase 2 trial of haploidentical natural killer cells in neuroblastoma, sponsored by University of Texas MD Anderson Cancer Center. Started Jun 2008; status: terminated.
02
Drugs
haploidentical natural killer cells
03
Conditions
neuroblastoma
Beyond the preview
Go deeper on NCT00698009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00698009.